Cargando…

C-Reactive Protein Is a Poor Marker of Baseline Inflammation in Prostate Cancer and Response to Radiotherapy or Androgen Ablation

Introduction C-reactive protein (CRP) is an acute-phase reactant used as a general marker for inflammation. Isolated levels have been associated with prostate cancer development, prostate-specific antigen (PSA), Gleason score, and treatment response. We seek to establish whether CRP levels reflect i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jensen, Garrett L, Naziri, Jason, Hammonds, Kendall P, Jhavar, Sameer G, Swanson, Gregory
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2021
Materias:	Radiation Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8673689/ https://www.ncbi.nlm.nih.gov/pubmed/34926085 http://dx.doi.org/10.7759/cureus.19639

Ejemplares similares

Bone Density Changes Following Radiotherapy to Vertebral Metastases
por: Jensen, Garrett L, et al.
Publicado: (2021)

The cost of elective nodal coverage in prostate cancer: Late quality of life outcomes and dosimetric analysis with 0, 45 or 54 Gy to the pelvis
por: Jensen, Garrett L., et al.
Publicado: (2022)

Reference Results for Blood Parameter Changes and Recovery after Pelvic Radiation without Chemotherapy
por: Swanson, Gregory P., et al.
Publicado: (2022)

The effect of pelvic radiation alone on lymphocyte subgroups
por: Swanson, Gregory P., et al.
Publicado: (2020)

The Effect of High-Dose Radiation Therapy on Healthy Vertebral Bone Density
por: Gaddipati, Ravi, et al.
Publicado: (2022)

Long-Term Effects of Radiation on Lymphocytes and Risk of Opportunistic Infections
por: Swanson, Gregory, et al.
Publicado: (2022)

Cryosurgery Versus Primary Androgen Deprivation Therapy for Locally Recurrent Prostate Cancer After Primary Radiotherapy: A Propensity-Matched Survival Analysis
por: Bauman, Glenn, et al.
Publicado: (2020)

Complete PSA Response Following Stereotactic Ablative Radiotherapy for a Bony Metastasis in the Setting of Castrate-Resistant Prostate Cancer
por: Lukovic, Jelena, et al.
Publicado: (2015)

Stereotactic Ablative Radiotherapy Fractionation for Hepatocellular Carcinoma in the United States
por: Sheth, Niki, et al.
Publicado: (2020)

Migration of implanted markers for image‐guided lung tumor stereotactic ablative radiotherapy
por: Hong, Julian C., et al.
Publicado: (2013)

Feed-forward alpha particle radiotherapy ablates androgen receptor-addicted prostate cancer
por: McDevitt, Michael R., et al.
Publicado: (2018)

Assessment of specific versus combined purpose knowledge based models in prostate radiotherapy
por: Bossart, Elizabeth, et al.
Publicado: (2018)

Commissioning and initial stereotactic ablative radiotherapy experience with Vero
por: Solberg, Timothy D., et al.
Publicado: (2014)

Intractable Pleural Effusion After Stereotactic Ablative Radiotherapy for Early-Stage Lung Cancer
por: Katano, Atsuto, et al.
Publicado: (2023)

Radiotherapy as a Single Modality in Primary Seminoma of the Prostate
por: Akingbade, Aquila, et al.
Publicado: (2021)

Improved Pathologic response to chemoradiation in MGMT methylated locally advanced rectal cancer
por: Jensen, Garrett L., et al.
Publicado: (2023)

Testosterone as a Biomarker for Quality of Life (QOL) Following Androgen Deprivation Therapy (ADT) and Stereotactic Body Radiotherapy (SBRT)
por: Shah, Sarthak, et al.
Publicado: (2023)

Metastasis-Directed Radiotherapy for Oligometastatic Castration-Resistant Prostate Cancer
por: Katano, Atsuto, et al.
Publicado: (2021)

TEAD1 and c-Cbl are novel prostate basal cell markers that correlate with poor clinical outcome in prostate cancer
por: Knight, J F, et al.
Publicado: (2008)

Dose escalated simultaneous integrated boost of gross nodal disease in gynecologic cancers: a multi-institutional retrospective analysis and review of the literature
por: Jensen, Garrett Lee, et al.
Publicado: (2021)

Phase II Trial of Pure Hypofractionated Radiotherapy in the Treatment of Localized Carcinoma of the Prostate
por: Gopaul, Darin, et al.
Publicado: (2018)

Evaluation of Safety for Scanning Carbon-Ion Radiotherapy in Hemodialysis Patients With Prostate Cancer
por: Takakusagi, Yosuke, et al.
Publicado: (2022)

Magnetic Resonance Imaging Guidance Mitigates the Effects of Intrafraction Prostate Motion During Stereotactic Body Radiotherapy for Prostate Cancer
por: Hegde, John V, et al.
Publicado: (2018)

Quantification of interplay and gradient effects for lung stereotactic ablative radiotherapy (SABR) treatments
por: Tyler, Madelaine K.
Publicado: (2016)

Recommendation of fiducial marker implantation for better target tracking using MV imager in prostate radiotherapy
por: Ma, Tianjun, et al.
Publicado: (2018)

Carbon ion radiotherapy using fiducial markers for prostate cancer in Osaka HIMAK: Treatment planning
por: Tsubouchi, Toshiro, et al.
Publicado: (2021)

Combined Immune Checkpoint Blockade and Stereotactic Ablative Radiotherapy Can Stimulate Response to Immunotherapy in Metastatic Melanoma: A Case Report
por: Moran, Angel, et al.
Publicado: (2019)

Implementation of Single-Fraction Lung Stereotactic Ablative Radiotherapy in a Multicenter Provincial Cancer Program During the COVID-19 Pandemic
por: Mou, Benjamin, et al.
Publicado: (2021)

Plan quality analysis of stereotactic ablative body radiotherapy treatment planning in liver tumor
por: Watcharawipha, Anirut, et al.
Publicado: (2023)

Automated prediction of dosimetric eligibility for hypofractionated prostate radiotherapy
por: Lausch, Anthony, et al.
Publicado: (2017)

Volumetric‐based image guidance is superior to marker‐based alignments for stereotactic body radiotherapy of prostate cancer
por: Li, Wen, et al.
Publicado: (2018)

MRI-guided Dose-escalated Salvage Radiotherapy for Bulky Bladder Neck Recurrence of Prostate Cancer
por: Kishan, Amar U, et al.
Publicado: (2018)

MDM2 Inhibition Sensitizes Prostate Cancer Cells to Androgen Ablation and Radiotherapy in a p53-Dependent Manner()()
por: Feng, Felix Y., et al.
Publicado: (2016)

Prostatic Acid Phosphatase Is a Progenitor Cell Marker That Persists After Androgen Ablation
por: Izadmehr, Sudeh, et al.
Publicado: (2021)

Immediate Versus Salvage Postoperative Radiotherapy in High-Risk Prostate Cancer Patients: A Critical Review
por: Berhili, Soufiane, et al.
Publicado: (2022)

Opposing effects of androgen ablation on immune function in prostate cancer
por: Tang, Shuai, et al.
Publicado: (2012)

Forward‐planning intensity‐modulated radiotherapy technique for prostate cancer
por: Metwaly, Mohamed, et al.
Publicado: (2007)

The effects of motion on the dose distribution of proton radiotherapy for prostate cancer
por: Qamhiyeh, Sima, et al.
Publicado: (2012)

Plan comparison of prostate stereotactic radiotherapy in spacer implant patients
por: Oki, Yuya, et al.
Publicado: (2021)

A Case of Metastatic Head and Neck Squamous Cell Carcinoma with Multiple Treatments Including Stereotactic Ablative Body Radiotherapy Alone for Oligometastases to the Parotid Gland
por: Sharrett, Jonathan, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_qgdfiqv7hmcgf62hk3ufjep53u